Controlled Release Pharmaceutical Compositions Comprising A Fumaric Acid Ester

Patent No. EP2801354 (titled "Controlled Release Pharmaceutical Compositions Comprising A Fumaric Acid Ester") was filed by Forward Pharma on Oct 7, 2005. The application was issued on Feb 8, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KELTIENov 8, 2017D YOUNG
PENTAFARMANov 8, 2017PATENTREE
STRAWMANNov 8, 2017GILL JENNINGS & EVERY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2801354

FORWARD PHARMA
Application Number
EP14172390A
Filing Date
Oct 7, 2005
Status
Revoked
Feb 10, 2023
Publication Date
Feb 8, 2017